jpm_asset_mgmt
  • Products

    Funds

    • Performance & Yields
    • Liquidity
    • Ultra-Short
    • Short Duration

    Solutions

    • Cash Segmentation
    • Separately Managed Accounts
    • Managed Reserves Strategy
    • Capitalizing on Prime Money Market Funds
  • Insights

    Liquidity Insights

    • Liquidity Insights Overview
    • Audio Commentaries
    • Case Studies
    • Leveraging the Power of Cash Segmentation
    • Cash Investment Policy Statement
    • China Money Market Resource Centre
    • PeerView Survey

    Market Insights

    • Market Insights Overview
    • Eye on the Market
    • Guide to the Markets
    • Market Updates

    Portfolio Insights

    • Portfolio Insights Overview
    • Currency
    • Fixed Income
    • Long-Term Capital Market Assumptions
    • Sustainable Investing
  • Resources
    • MORGAN MONEY
    • Account Management & Trading
    • Multimedia
    • Announcements
    • Total Return Comparison Calculator
  • About us
  • Contact us
Skip to main content
  • English
  • Role
  • Country
  • MORGAN MONEY LOGIN
Search
Menu
CLOSE
Search
You are about to leave the site Close
J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
CONTINUE Go Back
  1. Home
  2. Insights
  3. Market Insights Overview
  4. Market Updates
  5. On the Minds of Investors
  6. Will tensions between the U.S. and China keep rising?

  • Share
  • LinkedIn Twitter Facebook
  • Email
  • Print
  • Actions
  • LinkedIn Twitter Facebook
    Email Print

Will tensions between the U.S. and China keep rising?

08/12/2020

Gabriela Santos

While it may seem this way at times, it is not about the US or China, both will need to coexist in the global landscape for decades to come

Gabriela Santos

Gabriela Santos

Global Market Strategist

Listen to On the Minds of Investors

08/12/2020

It has become a near daily occurrence to awaken to headlines stating that “tensions between the U.S. and China are rising”. Indeed, tensions between the two countries have risen this year, a less positive example of a pre-pandemic trend that has gotten further amplified in the COVID-19 world. A spark was international concerns about China’s initial handling of COVID-19 and its transparency on the issue – and an accelerant has been the upcoming U.S. Presidential and Congressional election in November. 

Tensions will likely continue to rise in the lead up to the election, as both Republicans and Democrats compete on who would be tougher on China. A Pew Research Center survey conducted between mid-June to mid-July 2020, shows that 73% of U.S. adults have an unfavorable view of China, up from 47% in 2018. Republicans have a more unfavorable view of China than Democrats (83% vs. 68%), but the trend has been upwards regardless of partisan affiliation, making China a key campaign issue for both parties.

After the election has come and gone, the volume of tensions is likely to be dialed down, but to a new higher baseline. Competition between the U.S. and China is likely to be a key fixture of the investing landscape during our lifetimes – and perhaps beyond. As China’s economy, markets, innovation and military rivals the U.S. more and more, both countries will compete in a variety of spheres, including trade, technology, capital flows, human rights, security, health care and the environment. However, given the economic and geopolitical importance of both countries, competition is likely to be sprinkled with a mix of collaboration depending on the issue. 

As such, investors will need to invest through the heightened tensions by asking themselves the following questions: 

  1. In what type of sphere are the tensions taking place? Contrary to the past two years, this year’s tensions have not involved trade. In fact, the Phase I trade deal has been left in place so far. Instead, competition has been focused on technology, capital flows, human rights, security and health care.
  2. Does the action impact corporate fundamentals? Contrary to the 2018-2019 trade war, this year’s tensions have not involved spheres that have broad macro importance for markets. Some actions involving technology, capital flows and health care do have implications for specific companies; however, its more limited scope has kept the headlines high but the broad market volatility low. Should tensions move into the trade realm again, short-term volatility may pick up. In addition, it is key to look at any announcement in detail in order to see if it is more symbolism than substance in practice.
  3. Does this change the case for investing in China? China’s economy, equity market and bond market are now the second largest in the world. Over the next decade, China will not have as much of a tailwind for its growth as it did in the previous decades; however, it is on track to become a high income country, bringing up 500mn people into the middle class during this time period. The growth and development of their consumption patterns is one of the biggest growth opportunities of the next decade. In addition, Chinese technology companies are increasingly competitive on the global stage. Progressively, investors have more mature Chinese markets through which to access these themes – and more and more the need to go directly to the source to invest in them.  

While it may seem this way at times, it is not about the U.S. or China. Both will need to co-exist in the global landscape – and in investors’ portfolios as core holdings.

Competition between U.S and China takes many forms Year-to-date actions 

Type & scope U.S. action China action Risen this year? Matters to investors?
Trade
Goods, services, tariff and non-tariff barriers, industrial policy, currency
Signed Phase I deal in January; removed China as a currency manipulator Purchased 46% of prorated year-to-date target of U.S. goods; improved financial market openness; refrained from CNY devaluation

Technology
5G, AI, cloud computing, social media, digital payments, hardware, semiconductors
Pressured countries to remove Huawei from networks; restricted non-U.S. companies from producing Huawei chips; expanded list of Chinese companies on Entity List; proposed banning U.S. persons' transactions with TikTok & WeChat   Specific companies
Capital flows
Exchange listings, portfolio investments, foreign direct investment, banking system
Potential de-listing of Chinese ADRs based on U.S. audit requirements; restricted U.S. federal pension fund investments in Chinese companies Chinese companies started dual-listing on HK/mainland exchanges in anticipation of U.S. exchange listing changes Specific companies
Human rights
Hong Kong national security law, China's treatment of Uighurs in Xinjiang
Sanctioned 11 Chinese/HK individuals involved with HK law; suspended HK's preferential treatment over China; sanctioned 6 Chinese individuals and 1 entity related to treatment of Uighurs Sanctioned 11 U.S. individuals in retaliation for HK-related sanctions; sanctioned 4 U.S. individuals in retaliation for Uighurs-related sanctions
Security
South China Sea, Taiwan, Belt and Road Initiative, ideology, cybersecurity
Declared China's claims on South China Sea illegal and continued naval exercises; closed Chinese consulate in Houston; restricted number of Chinese journalists in the U.S.; first senior U.S. official visit to Taiwan in 40 years Continued incursions in South China Sea; closed U.S. consulate in Chengdu; expelled U.S. journalists from China; sanctioned Lockheed Martin for its involvement in U.S. arms sale to Taiwan
Health care
Production of medical equipment and PPE, biotech, R&D
Blamed China for COVID-19 spread; competing in race for COVID-19 vaccine/treatment; charged two Chinese hackers for allegedly stealing vaccine research; proposed bills to re-shore production of medical equipment , PPE, and pharma Blamed U.S. for COVID-19 spread; competing in race for COVID-19 vaccine/treatment Specific companies
Environment
Climate change, renewable energy, energy efficiency
    Specific companies

Source : GovTrack, National news outlets, Peterson Institute for International Economics, U.S. Treasury, J.P. Morgan Asset Management. Data are as of August 12, 2020.

0903c02a829a5212

EXPLORE MORE

On the Minds of Investors

What investment questions are on the minds of investors? Explore the questions investors ask frequently and find answers at J.P. Morgan Asset Management.

Read more

Guide to the Markets

The J.P. Morgan Guide to the Markets illustrates a comprehensive array of market and economic histories, trends and statistics through clear charts and graphs.

Read more

Asset Class Views

Get quarterly commentary and in-depth analysis on equities, fixed income and other asset classes, written by our senior investment teams.

Read more
Markets Economy
J.P. Morgan Asset Management

  • Investment stewardship
  • About us
  • Contact us
  • Privacy policy
  • Cookie policy
  • Binding corporate rules
  • Sitemap
  • Accessibility
Decorative
J.P. Morgan

  • J.P. Morgan
  • JPMorgan Chase
  • Chase

READ IMPORTANT LEGAL INFORMATION. CLICK HERE >

The value of investments may go down as well as up and investors may not get back the full amount invested.

Copyright 2021 JPMorgan Chase & Co. All rights reserved.